Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dyadic International Inc

DYAI
Current price
1.73 USD +0.01 USD (+0.58%)
Last closed 1.77 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 50 995 648 USD
Yield for 12 month +23.57 %
Week
Month
Year
DYAI
21.11.2021 - 28.11.2021

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. It utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus-like particles, protein antigens, ferritin nanoparticles, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to demonstrate the safety in humans of a protein produced from C1-cell protein production platform. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; and strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., as well as co-development and marketing agreement with Fermbox Bio Inc to design,Develop, and commercialize animal free alternative proteins and biomaterials The company was founded in 1979 and is headquartered in Jupiter, Florida. Address: 140 Intracoastal Pointe Drive, Jupiter, FL, United States, 33477-5094

Analytics

WallStreet Target Price

7.5 USD

P/E ratio

Dividend Yield

0.84 %

Current Year

+2 930 303 USD

Last Year

+2 403 831 USD

Current Quarter

+397 060 USD

Last Quarter

+837 159 USD

Current Year

+807 110 USD

Last Year

+459 393 USD

Current Quarter

+291 191 USD

Last Quarter

+44 215 USD

Key Figures DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM -430.04 %
PE Ratio
Return On Assets TTM -42.06 %
PEG Ratio
Return On Equity TTM -67.8 %
Wall Street Target Price 7.5 USD
Revenue TTM 2 955 997 USD
Book Value 0.27 USD
Revenue Per Share TTM 0.1 USD
Dividend Share
Quarterly Revenue Growth YOY -54.9 %
Dividend Yield 0.84 %
Gross Profit TTM 807 110 USD
Earnings Share -0.23 USD
Diluted Eps TTM -0.23 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -232.41 %

Dividend Analytics DYAI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 0.84 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 15.8228
Enterprise Value Revenue 14.2921
Price Sales TTM 17.2516
Enterprise Value EBITDA -5.1295
Price Book MRQ 6.5698

Financials DYAI

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators DYAI

For 52 weeks

1.12 USD 2.4 USD
50 Day MA 1.78 USD
Shares Short Prior Month 183 677
200 Day MA 1.81 USD
Short Ratio 10.23
Shares Short 177 877
Short Percent 0.88 %